Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound

Cancer

Volumn 116, Issue 16, 2010, Pages 3934-3942

  Li, Chuanxing ^a   Zhang, Weidong ^a   Fan, Weijun ^a   Huang, Jinhua ^a   Zhang, Fujun ^a   Wu, Peihong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Ablation; Chemotherapy; High intensity focused ultrasound; Intervention; Malignant bone tumor; Ultrasonography

Indexed keywords

BIOCHEMICAL MARKER; CISPLATIN; DOXORUBICIN; GADOLINIUM PENTETATE; MEDRONATE TECHNETIUM TC 99M; METHOTREXATE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE PAIN; BONE TUMOR; BURN; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FEVER; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LIMB SWELLING; MALE; MULTIPLE CYCLE TREATMENT; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OVERALL SURVIVAL; PAIN ASSESSMENT; PATIENT SAFETY; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SWELLING; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; BONE NEOPLASMS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PAIN MEASUREMENT; POSITRON EMISSION TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN MEASUREMENT; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956804936     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25192     Document Type: Article

References (24)

1. Berenson JR, Rajder L, Broder M. Pathophysiology of bone metastases. Cancer Biol Ther. 2006;5:1078-1081.
2. Hoegler D. Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer. 1997;21:129-183.
3. Mereadante S, Fulfaro F. Management of painful bone metastases. Curr Opin Oncol. 2007;19:308-314.
4. Body JJ, Diel IJ, Lichinister MR. Oral ibandronate reduces the risk of skeletal complication in breast cancer patients with metastatic bone disease. Br J Cancer. 2004;90:1133-1137.
5. Siegel HJ, Pressey JG. Current concepts on the surgical and medical management of osteosarcoma. Expert Rev Anticancer Ther. 2008;8:1257-1269.
6. Shalaby S, Shalaby H, Bassiony A, et al. Limb salvage for osteosarcoma of the distal tibia with resection arthrodesis: autogenous fibular graft and Ilizarov external fixator. J Bone Joint Surg Br. 2006;88:1642-1646. (Pubitemid 44970695)
7. Aliaev G, Krupinov GE, Bezrukov EA, Grigorian VA, Amosov AV. Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device. Urologiia. 2007;6:39-44.
8. Thuroff S, Chaussy C. HIFU in urological oncology. Urologe A. 2008;47:431-440.
9. Ana A, Murat FJ, Walter B, et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol. 2008;53:1194-1201.
10. ter Haar G. High intensity ultrasound. Semin Laparosc Surg. 2001;8:77-89.
11. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099-1106. (Pubitemid 32807732)
12. Wu F, Wang ZB, Chen WZ, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004;30:245-260. (Pubitemid 38293277)
13. Ter Haar GR. High intensity focused ultrasound for the treatment of tumors. Echocardiography. 2001;18:317-322. (Pubitemid 32579094)
14. Wu F, Chen WZ, Bai J, et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol. 2002;28:535-542. (Pubitemid 34603773)
15. Li CX, Xu GL, Li JJ, et al. High intensity focused ultrasound for liver cancer. Zhonghua Zhongliu Zazhi. 2003;25:94-96.
16. World Health Organization. Cancer Pain Relief With a Guide to Opioid Availability. Geneva, Switzerland: World Health Organization; 1996.
17. Leslie TA, Kennedy JE, Illing RO, et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? Br J Radiol. 2008;81:564-571.
18. Markus U, Ulrich S, Gabriele K, et al. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol. 2006;36:1306-1311.
19. Li F, Wang Z, Du Y. Study on therapeutic dosimetry of HIFU ablation tissue [in Chinese]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006;23:839-843.
20. Chen W, Wang Z, Wu F, et al. High intensity focused ultrasound in the treatment of primary malignant bone tumor [in Chinese]. Zhonghua Zhong Liu Za Zhi. 2002;24:612-615.
21. Wang Z, Bai J, Li F, et al. Study of a "biological focal region" of high-intensity focused ultrasound. Ultrasound Med Biol. 2003;29:749-754.
22. Hynynen K, Colucci V, Chung A, et al. Noninvasive arterial occlusion using MRI-guided focused ultrasound. Ultrasound Med Biol. 1996;22:1071-1077. (Pubitemid 26423862)
23. Damianou C. MRI monitoring of the effect of tissue interfaces in the penetration of high intensity focused ultrasound in kidney in vivo. Ultrasound Med Biol. 2004;30:1209-1215. (Pubitemid 39531626)
24. Yang R, Reilly CR, Rescorla FJ, et al. High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg. 1991;126:1002-1009.